| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1368790 | Bioorganic & Medicinal Chemistry Letters | 2016 | 8 Pages | 
Abstract
												We have identified a class of azabenzimidazoles as potent and selective JAK1 inhibitors. Investigations into the SAR are presented along with the structural features required to achieve selectivity for JAK1 versus other JAK family members. An example from the series demonstrated highly selective inhibition of JAK1 versus JAK2 and JAK3, along with inhibition of pSTAT3 in vivo, enabling it to serve as a JAK1 selective tool compound to further probe the biology of JAK1 selective inhibitors.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
												
											Related Topics
												
													Physical Sciences and Engineering
													Chemistry
													Organic Chemistry
												
											Authors
												Melissa M. Vasbinder, Marat Alimzhanov, Martin Augustin, Geraldine Bebernitz, Kirsten Bell, Claudio Chuaqui, Tracy Deegan, Andrew D. Ferguson, Kelly Goodwin, Dennis Huszar, Aarti Kawatkar, Sameer Kawatkar, Jon Read, Jie Shi, Stefan Steinbacher, 
											